Keyphrases
Acquired Hemophilia A
21%
African American
20%
Aggregation Rate
17%
AIDS/HIV
24%
Ankle-brachial Index
17%
Anticoagulant Therapy
19%
Anticoagulants
22%
Aspirin
32%
Autoantibodies
27%
Bleeding
70%
Bleeding Time
32%
Clot
18%
Clotting Factors
25%
Coagulant Activity
17%
Coagulation
32%
Confidence Interval
18%
Coronary Artery Risk Development in Young Adults
38%
Cyclophosphamide
20%
D-dimer
47%
Deep Vein Thrombosis
44%
Factor VIII Concentrate
18%
Factor VIII Inhibitor
26%
Fibrinogen
74%
Hematin
22%
Hemophilia
56%
Hemophilia Patients
32%
Hemophiliacs
31%
Hemostasis
19%
Hemostatic Factors
33%
Heparin
53%
Inflammatory Markers
18%
Low Molecular Weight Heparin
57%
Peripheral Arterial Disease
82%
Platelet Aggregation
24%
Platelet Count
16%
Platelet Function
31%
Platelets
89%
Prothrombin Complex Concentrate
17%
Ristocetin
37%
Spinal Cord Injury
32%
Systemic Lupus Erythematosus
17%
Thrombocytopenia
26%
Thromboembolism
30%
Thromboprophylaxis
20%
Thrombosis
36%
Venous Thromboembolism
35%
Venous Thrombosis
23%
Von Willebrand Disease
52%
Von Willebrand Factor
90%
Warfarin
50%
Pharmacology, Toxicology and Pharmaceutical Science
Acetylsalicylic Acid
29%
Aminocaproic Acid
11%
Anticoagulant Agent
28%
Atrial Fibrillation
11%
Autoantibodies
13%
Biological Marker
11%
Bleeding
88%
Blood Clotting Factor
28%
Blood Clotting Factor 7
18%
Blood Clotting Factor 8
100%
Blood Clotting Factor 8 Concentrate
14%
Blood Clotting Factor 8 Inhibitor
21%
Blood Stasis
25%
Cerebrovascular Accident
12%
D Dimer
17%
Deep Vein Thrombosis
30%
Diflunisal
11%
Diseases
28%
Disseminated Intravascular Clotting
17%
Fibrinogen
42%
Fibrinolytic Agent
11%
Fibrinopeptide A
12%
Haemophilia A
61%
Hematin
22%
Hemostatic Agent
21%
Heparin
48%
Interleukin 6
15%
Ischemic Heart Disease
12%
Low Molecular Weight Heparin
54%
Malignant Neoplasm
11%
Normal Human
16%
Peripheral Occlusive Artery Disease
38%
Phospholipid
11%
Placebo
21%
Procoagulant
11%
Protein C
12%
Prothrombin
28%
Ristocetin
31%
Sickle Cell Crisis
11%
Spinal Cord Injury
28%
Syndrome
12%
Thrombin
19%
Thromboembolism
30%
Thromboplastin
14%
Thrombosis
29%
Vein Thrombosis
14%
Venous Thromboembolism
28%
Von Willebrand Disease
32%
Von Willebrand Factor
55%
Warfarin
43%
Medicine and Dentistry
Acquired Immune Deficiency Syndrome
11%
Ankle Brachial Index
12%
Anticoagulation
11%
Antiphospholipid Antibody
12%
Antithrombotic
18%
Apoplexy
27%
Arteriosclerosis Obliterans
55%
Atherosclerosis
11%
Atrial Fibrillation
12%
Autoantibodies
17%
Biological Marker
13%
Bleeding
67%
Bleeding Time
16%
Blood Clotting Factor
22%
Blood Clotting Factor 8
74%
Blood Clotting Factor 8 Inhibitor
13%
Blood Stasis
15%
Body Mass Index
11%
Coronary Artery
27%
D-Dimer
30%
Deep Vein Thrombosis
30%
Diseases
28%
Disseminated Intravascular Coagulation
18%
Factor VII
21%
Fibrinogen
44%
Fibrinolysis
15%
Fibrinopeptide A
10%
Haemophilia A
45%
Hemostat
41%
Heparin
39%
Infusion
17%
Low Molecular Weight Heparin
29%
Malignant Neoplasm
11%
Phlebothrombosis
20%
Platelet
50%
Procoagulant
10%
Prothrombin
12%
Pulmonary Embolism
12%
Recombinant Blood Clotting Factor 7a
13%
Ristocetin
17%
Spinal Cord Injury
28%
Statin
11%
Thrombocyte Function
15%
Thromboembolism
25%
Thromboprophylaxis
14%
Thrombosis
29%
Venous Thromboembolism
28%
Von Willebrand Disease
42%
Von Willebrand Factor
66%
Warfarin
17%